4ZDX

Structure of OXA-51 beta-lactamase

4ZDX の概要

• エントリーDOI: 10.2210/pdb4zdx/pdb
• 分子名称: Beta-lactamase, 2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXYL, GLYCEROL, ... (4 entities in total)
• 機能のキーワード: antibiotic resistance, beta-lactamase, carbapenemase, mutant, hydrolase
• 由来する生物種: Acinetobacter baumannii
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 30958.40

構造登録者

Smith, C.A.,Antunes, N.T.,Stewart, N.K.,Frase, H.,Toth, M.,Kantardjieff, K.A.,Vakulenko, S.B. (登録日: 2015-04-20, 公開日: 2015-06-17, 最終更新日: 2015-09-02)

主引用文献

Smith, C.A.,Antunes, N.T.,Stewart, N.K.,Frase, H.,Toth, M.,Kantardjieff, K.A.,Vakulenko, S.
Structural Basis for Enhancement of Carbapenemase Activity in the OXA-51 Family of Class D beta-Lactamases.
Acs Chem.Biol., 10:1791-1796, 2015

PubMed Abstract: Class D β-lactamases of Acinetobacter baumannii are enzymes of the utmost clinical importance, producing resistance to last resort carbapenem antibiotics. Although the OXA-51-like enzymes constitute the largest family of class D β-lactamases, they are poorly studied and their importance in conferring carbapenem resistance is controversial. We present the detailed microbiological, kinetic, and structural characterization of the eponymous OXA-51 β-lactamase. Kinetic studies show that OXA-51 has low catalytic efficiency for carbapenems, primarily due to the low affinity of the enzyme for these substrates. Structural studies demonstrate that this low affinity results from the obstruction of the enzyme active site by the side chain of Trp222, which presents a transient steric barrier to an incoming carbapenem substrate. The Trp222Met substitution relieves this steric hindrance and elevates the affinity of the mutant enzyme for carbapenems by 10-fold, significantly increasing the levels of resistance to these antibiotics. The ability of OXA-51 to evolve into a robust carbapenemase as the result of a single amino acid substitution may, in the near future, elevate the ubiquitous enzymes of the OXA-51 family to the status of the most deleterious A. baumannii carbapenemases, with dire clinical consequences.

PubMed: 26042471
DOI: 10.1021/acschembio.5b00090

実験手法

X-RAY DIFFRACTION (2.001 Å)